Latest News about RYTM
Recent news which mentions RYTM
These Mid-Cap Stocks Outshone The Market Volatility Last Week (Apr 7-Apr 11): Are These In Your Portfolio?
April 13, 2025
From Benzinga
Marvell Technology, Nvidia, Tesla, Apple And Other Big Stocks Moving Higher On Tuesday
April 08, 2025
From Benzinga
From Benzinga
Rhythm Pharmaceuticals Weight Loss Drug Study Shows Significant BMI Reduction For Rare Type Of Obesity Disorder
April 07, 2025
From Benzinga
Earnings Scheduled For February 26, 2025
February 26, 2025
From Benzinga
7 Analysts Assess Rhythm Pharmaceuticals: What You Need To Know
February 19, 2025
Tickers
RYTM
From Benzinga
Rhythm Pharmaceuticals' Obesity Treatments Target Less Crowded Space, Analyst Sees Long-Term Potential
December 20, 2024
From Benzinga
Critical Insights From Rhythm Pharmaceuticals Analyst Ratings: What You Need To Know
October 25, 2024
Tickers
RYTM
From Benzinga
What 4 Analyst Ratings Have To Say About Rhythm Pharmaceuticals
September 18, 2024
Tickers
RYTM
From Benzinga
Tickers
RYTM
From InvestorPlace
The 3 Best Nasdaq Stocks to Buy in May 2024
May 07, 2024
From InvestorPlace
Tickers
RYTM
From InvestorPlace
Jim Cramer Is 'Willing To Let This Pharma Stock Catch Fire,' Advises Not To Sell McKesson
April 19, 2024
From Benzinga
Analyst Expectations For Rhythm Pharmaceuticals's Future
February 22, 2024
Tickers
RYTM
From Benzinga
Earnings Scheduled For February 22, 2024
February 22, 2024
From Benzinga
The Analyst Verdict: Rhythm Pharmaceuticals In The Eyes Of 7 Experts
January 04, 2024
Tickers
RYTM
From Benzinga
Analyst Expectations for Rhythm Pharmaceuticals's Future
December 07, 2023
Tickers
RYTM
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.